GE Healthcare Initiates Investment in CMR Surgical
Posted on December 02, 2019 by Medtech[y] Staff
CMR Surgical, developer of the Versius Surgical Robotic System, announced the initiation of an investment by GE Healthcare during the company's recent $240 million Series C financing round.
The investment by GE Healthcare provides confidence for the Versius system from a blue chip company, which should demonstrate the potential benefits that GE sees for Versius as CMR continues to develop and go to market with the system.
Martin Frost, Chief Executive Officer of CMR Surgical, said: “We are delighted to have attracted investment from GE Healthcare, one of the world’s most respected healthcare companies, to bring advanced technologies to market in a way that has the potential to benefit surgeons and their patients.”
What is the Versius Surgical Robotic System?
President and CEO of Image Guided Therapies at GE Healthcare, Gustavo Perez-Fernandez, shares CMR Surgical’s vision of making minimal access surgery available to all.
“We see the Versius surgical robotic system being a key ‘guiding companion’ for surgeons as they pursue minimal access surgery. Along with GE Healthcare’s advanced, high-quality imaging, digital and artificial intelligence tools, we can bring minimal access surgery to more people. CMR Surgical and GE Healthcare both have the potential to transform the way surgeries are performed worldwide and this investment underlines the shared ambition to do so.”
GE Healthcare is currently present in operating rooms around the world, with the OEC portfolio of surgical imaging systems. The OEC systems provide real-time imaging to guide surgeons during procedures, enabling them to “see” inside a patient.
CMR Surgical recently announced its first commercial installations of the Versius surgical robotic system. Versius is a small, modular, and cost-effective robotic system designed to help surgeons and healthcare providers bring the benefits of minimal access surgery to patients around the world.